Date & Time:
LIVE: May 14, 2026 7:00–8:15 PM EDT
Rebroadcast: May 21, 2026 7:00–8:15 PM CET
Rebroadcast: May 21, 2026 7:00–8:15 PM CET
Moderator: Dr. Partho P. Sengupta, MD, MBBS, FACC
Cardiologist, Professor of Medicine,
Chief of the Division of Cardiology at Rutgers Robert Wood Johnson Medical School,
Chief of the Cardiovascular Service Line at Robert Wood Johnson University Hospital,
New Brunswick, NJ, the USA
Dr. Partho P. Sengupta, MD, MBBS, FACC, is a tenured Professor of Medicine, Chief of the Division of Cardiology at Rutgers Robert Wood Johnson Medical School, and Chief of the Cardiovascular Service Line at Robert Wood Johnson University Hospital. He completed his residency and cardiology fellowship at the Mayo Clinic (Rochester and Arizona) in 2007 and 2010.
An internationally recognized leader in cardiac imaging, digital health, and artificial intelligence, Dr. Sengupta has authored more than 330 peer-reviewed publications (H-index: 72). His research focuses on advanced ultrasound imaging, AI-enabled diagnostics, robotics, and wearable technologies. He has directed multidisciplinary teams to pioneer mobile health and point-of-care ultrasound programs, including landmark ASE Foundation initiatives such as ASE-REWARDS, ASE-VISION-in-Tele-Echo, and ASEF-VALUES, which advanced community outreach, digital platforms, and global learning in echocardiography.
Dr. Sengupta has also made milestone contributions to imaging informatics. He reported one of the earliest applications of machine learning in echocardiography (2013) and more recently led the development of the PRIME checklist, now adopted by the ACC and JACC: Cardiovascular Imaging as the standard framework for evaluating artificial intelligence in cardiovascular imaging.
His achievements have been widely recognized. He received the 2026 Distinguished Scientist Award (Translational Domain), was named among the Top 1% Healthcare Research All-Stars for 2025 by Avant-Garde Health, and received the 2024 AACIO Award for Outstanding Achievements in Cardiology, the 2023 NJBiz Healthcare Hero Award, and the 2023 ACC Gifted Educator Award. In 2025, he was appointed Co-Chair of the NIH Study Section for K Awards, reflecting his national leadership in physician-scientist training. He will also serve as Abstract Chair for the ASE Annual Scientific Sessions (2026–2027) and Overall Scientific Session Chair (2027–2028).
Through innovation centers at West Virginia University and Rutgers, supported by NSF, NHLBI, and industry grants, Dr. Sengupta has fostered breakthrough discoveries, patents, and industry collaborations. He has mentored more than 30 national and international research trainees, many of whom have achieved recognition as Young Investigator Award finalists.
Cardiologist, Professor of Medicine,
Chief of the Division of Cardiology at Rutgers Robert Wood Johnson Medical School,
Chief of the Cardiovascular Service Line at Robert Wood Johnson University Hospital,
New Brunswick, NJ, the USA
Dr. Partho P. Sengupta, MD, MBBS, FACC, is a tenured Professor of Medicine, Chief of the Division of Cardiology at Rutgers Robert Wood Johnson Medical School, and Chief of the Cardiovascular Service Line at Robert Wood Johnson University Hospital. He completed his residency and cardiology fellowship at the Mayo Clinic (Rochester and Arizona) in 2007 and 2010.
An internationally recognized leader in cardiac imaging, digital health, and artificial intelligence, Dr. Sengupta has authored more than 330 peer-reviewed publications (H-index: 72). His research focuses on advanced ultrasound imaging, AI-enabled diagnostics, robotics, and wearable technologies. He has directed multidisciplinary teams to pioneer mobile health and point-of-care ultrasound programs, including landmark ASE Foundation initiatives such as ASE-REWARDS, ASE-VISION-in-Tele-Echo, and ASEF-VALUES, which advanced community outreach, digital platforms, and global learning in echocardiography.
Dr. Sengupta has also made milestone contributions to imaging informatics. He reported one of the earliest applications of machine learning in echocardiography (2013) and more recently led the development of the PRIME checklist, now adopted by the ACC and JACC: Cardiovascular Imaging as the standard framework for evaluating artificial intelligence in cardiovascular imaging.
His achievements have been widely recognized. He received the 2026 Distinguished Scientist Award (Translational Domain), was named among the Top 1% Healthcare Research All-Stars for 2025 by Avant-Garde Health, and received the 2024 AACIO Award for Outstanding Achievements in Cardiology, the 2023 NJBiz Healthcare Hero Award, and the 2023 ACC Gifted Educator Award. In 2025, he was appointed Co-Chair of the NIH Study Section for K Awards, reflecting his national leadership in physician-scientist training. He will also serve as Abstract Chair for the ASE Annual Scientific Sessions (2026–2027) and Overall Scientific Session Chair (2027–2028).
Through innovation centers at West Virginia University and Rutgers, supported by NSF, NHLBI, and industry grants, Dr. Sengupta has fostered breakthrough discoveries, patents, and industry collaborations. He has mentored more than 30 national and international research trainees, many of whom have achieved recognition as Young Investigator Award finalists.
Panelist: Dr. Joao Lima, MD
Director of Cardiovascular Imaging at the Johns Hopkins Hospital,
Professor of Medicine, Radiology and Epidemiology
at the Johns Hopkins School of Medicine,
Baltimore, MD, the USA.
Dr. Joao Lima is a professor of medicine, radiology and epidemiology at the Johns Hopkins School of Medicine. His pioneering work in cardiac imaging using advanced MRI, CT and echocardiography has led to noninvasive techniques for predicting cardiovascular disease and calculating its extent, as well as measuring the effectiveness of modern cardiac treatments. He holds numerous patents on devices and methods for cardiac imaging and image-guided therapies.
Dr. Lima graduated medical school at the University of Bahia, Brazil. He completed his cardiology fellowship at Johns Hopkins and spent two years on the faculty of the University of Pennsylvania before returning to Hopkins as a faculty member in 1992. A long-time investigator with the Multi-Ethnic Study of Atherosclerosis (MESA), Dr. Lima is credited with more than 175 articles out of that study and nearly 575 publications over his career. He is associate editor of Journal of the American College of Cardiology and serves on the editorial board of the Italian Journal of Cardiology while reviewing for other journals including the New England Journal of Medicine, Circulation and Annals of Internal Medicine. Dr. Lima has been invited to present his research throughout the Americas, Europe and Asia.
Director of Cardiovascular Imaging at the Johns Hopkins Hospital,
Professor of Medicine, Radiology and Epidemiology
at the Johns Hopkins School of Medicine,
Baltimore, MD, the USA.
Dr. Joao Lima is a professor of medicine, radiology and epidemiology at the Johns Hopkins School of Medicine. His pioneering work in cardiac imaging using advanced MRI, CT and echocardiography has led to noninvasive techniques for predicting cardiovascular disease and calculating its extent, as well as measuring the effectiveness of modern cardiac treatments. He holds numerous patents on devices and methods for cardiac imaging and image-guided therapies.
Dr. Lima graduated medical school at the University of Bahia, Brazil. He completed his cardiology fellowship at Johns Hopkins and spent two years on the faculty of the University of Pennsylvania before returning to Hopkins as a faculty member in 1992. A long-time investigator with the Multi-Ethnic Study of Atherosclerosis (MESA), Dr. Lima is credited with more than 175 articles out of that study and nearly 575 publications over his career. He is associate editor of Journal of the American College of Cardiology and serves on the editorial board of the Italian Journal of Cardiology while reviewing for other journals including the New England Journal of Medicine, Circulation and Annals of Internal Medicine. Dr. Lima has been invited to present his research throughout the Americas, Europe and Asia.
Panelist: Dr. Sanjeevan Pasupati, MB ChB, FRACP, FCSANZ
Interventional Cardiologist,
Director, Structural Heart Disease & Cardiovascular Research Unit,
Waikato Hospital,
Hamilton, New Zealand
Dr. Sanjeevan Pasupati is an interventional cardiologist specializing in angioplasty and percutaneous treatment of valvular and structural heart disease. He serves as Director of the Structural Heart Disease & Cardiovascular Research Unit at Waikato Hospital, where he also oversees the governance of the catheterization laboratory.His research focuses on the development and clinical evaluation of novel devices for structural and coronary heart disease, and he has published widely in these fields.Dr. Pasupati played a pioneering role in establishing transcatheter aortic valve implantation (TAVI) in New Zealand’s public healthcare system and has mentored institutions both locally and internationally in developing TAVI programs.He is a frequent invited speaker at international cardiology meetings and serves on advisory boards for several medical device companies.
Interventional Cardiologist,
Director, Structural Heart Disease & Cardiovascular Research Unit,
Waikato Hospital,
Hamilton, New Zealand
Dr. Sanjeevan Pasupati is an interventional cardiologist specializing in angioplasty and percutaneous treatment of valvular and structural heart disease. He serves as Director of the Structural Heart Disease & Cardiovascular Research Unit at Waikato Hospital, where he also oversees the governance of the catheterization laboratory.His research focuses on the development and clinical evaluation of novel devices for structural and coronary heart disease, and he has published widely in these fields.Dr. Pasupati played a pioneering role in establishing transcatheter aortic valve implantation (TAVI) in New Zealand’s public healthcare system and has mentored institutions both locally and internationally in developing TAVI programs.He is a frequent invited speaker at international cardiology meetings and serves on advisory boards for several medical device companies.
Panelist: Dr. Kanae Mukai, MD, FACC, ABIHM, FSCMR
Cardiologist,
Medical Director, Non-Invasive Cardiovascular Imaging,
Ryan Ranch Center for Advanced Diagnostic Imaging,
Salinas Valley Memorial Healthcare System,
California, USA
Dr. Kanae Mukai, MD, FACC, ABIHM, FSCMR, is the Medical Director of Non-Invasive Cardiovascular Imaging at Ryan Ranch Center for Advanced Diagnostic Imaging and Salinas Valley Memorial Healthcare System and a practicing cardiologist who leads imaging initiatives for structural heart interventions. She obtained her BS in chemical engineering from MIT and previously worked in the semiconductor industry in various applications engineering and product management roles at a capital equipment company supplying process control and yield management systems. She obtained her MD at Chicago Medical School and completed her internal medicine residency at Mayo Clinic, fellowships in general and integrative cardiology at Scripps Clinic, and advanced imaging subspecialty fellowships at Duke Cardiovascular Magnetic Resonance Center and UCSF. She holds Level 3 certification and is a boarded Diplomate in MRI, CT, nuclear imaging, and echocardiography. Dr. Mukai is a member of the Board of Directors for the Society of Cardiovascular Magnetic Resonance (SCMR) and Society of Cardiovascular Computed Tomography (SCCT). She is the Program Chair for the 2027 Scientific Sessions, Immediate Past Chair of the Public Relations Committee, and was the Abstract Chair for the 2026 Scientific Sessions. Her research interests include parametric mapping, MRI with cardiac devices, 4D flow, and non-contrast vascular imaging.
Cardiologist,
Medical Director, Non-Invasive Cardiovascular Imaging,
Ryan Ranch Center for Advanced Diagnostic Imaging,
Salinas Valley Memorial Healthcare System,
California, USA
Dr. Kanae Mukai, MD, FACC, ABIHM, FSCMR, is the Medical Director of Non-Invasive Cardiovascular Imaging at Ryan Ranch Center for Advanced Diagnostic Imaging and Salinas Valley Memorial Healthcare System and a practicing cardiologist who leads imaging initiatives for structural heart interventions. She obtained her BS in chemical engineering from MIT and previously worked in the semiconductor industry in various applications engineering and product management roles at a capital equipment company supplying process control and yield management systems. She obtained her MD at Chicago Medical School and completed her internal medicine residency at Mayo Clinic, fellowships in general and integrative cardiology at Scripps Clinic, and advanced imaging subspecialty fellowships at Duke Cardiovascular Magnetic Resonance Center and UCSF. She holds Level 3 certification and is a boarded Diplomate in MRI, CT, nuclear imaging, and echocardiography. Dr. Mukai is a member of the Board of Directors for the Society of Cardiovascular Magnetic Resonance (SCMR) and Society of Cardiovascular Computed Tomography (SCCT). She is the Program Chair for the 2027 Scientific Sessions, Immediate Past Chair of the Public Relations Committee, and was the Abstract Chair for the 2026 Scientific Sessions. Her research interests include parametric mapping, MRI with cardiac devices, 4D flow, and non-contrast vascular imaging.
Due to medical device regulatory reasons, not all products/service displayed on this webpage are available in all countries, regions or markets. Future availability of the products/service cannot also be guaranteed. Please contact your local Canon Medical Group representative for further details.
Development and manufacturing functions of Canon Medical Systems Corporation have been transferred to CANON INC. In this website, any reference to “Canon Medical Systems Corporation” refers to “CANON INC.”
Development and manufacturing functions of Canon Medical Systems Corporation have been transferred to CANON INC. In this website, any reference to “Canon Medical Systems Corporation” refers to “CANON INC.”
